The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.
Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.
The researchers observed between-group differences between real and sham acupuncture treatment.
Studies have found only small improvements in treating depression with Omega-3s and have been of low-quality.
Patients with psychosis and addiction disorders responded moderately better to disorder-specific treatment.
Patients in coordinated care remained in treatment longer and experienced greater improvements in their symptoms, compared with standard-care patients.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Childhood-Onset Bipolar Disorder Associated With Impaired Family Functioning
- Valproate Use in Women Who Could Become Pregnant: The Argument for Informed Consent
- Review Examines the Effectiveness of Antidepressants for Insomnia
- Ketamine-Induced Dissociative Symptoms Predict Antidepressant Response
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- New APA President Takes Office as the First African-American to Lead the Organization
- "MDMA-Assisted Psychotherapy Effective for Treating PTSD in Veterans, First Responders "
- Early Intervention Services Superior to Treatment as Usual for Early-Phase Psychosis
- Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA
- Gender-Related Association Between Physical Activity, Psychological Status in T2D